4.6 Review

The Role of Noninvasive Imaging in Coronary Artery Disease Detection, Prognosis, and Clinical Decision Making

期刊

CANADIAN JOURNAL OF CARDIOLOGY
卷 29, 期 3, 页码 285-296

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.cjca.2012.10.022

关键词

-

资金

  1. Canadian Institutes for Health Research [CIHR] [CIF 99470]
  2. CIHR [MSH-83718]
  3. Ontario Research Fund: Imaging for Cardiovascular Therapeutics
  4. GE Healthcare
  5. Pfizer
  6. AstraZeneca

向作者/读者索取更多资源

A vast array of noninvasive imaging modalities is available for the evaluation of the presence and severity of coronary artery disease (CAD). Choosing the right test can be challenging but is critical for proper patient diagnosis and management. Presently available imaging tests for CAD include: (1) nuclear myocardial perfusion imaging procedures (single-photon emission tomography) and positron emission tomography, (2) stress echocardiography, (3) computed tomography coronary angiography, and (4) cardiac magnetic resonance imaging. Exercise treadmill testing electrocardiography is another alternative that we will discuss briefly. Selection of the most appropriate imaging modality requires knowledge of the clinical question being addressed, patient characteristics (pretest probability and prevalence of disease), the strengths, limitations, risks, costs, and availability of each procedure. To assist with test selection, we review the relevant literature in detail to consider the relative merits of cardiac imaging modalities for: (1) detection of CAD, (2) risk stratification and prognostication, and (3) guiding clinical decision making.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据